WELCURE DRUGS & PHARMACEUTICALS LTD.
BSE: 524661
values in crores
Revenue & Profit Trend
in croresRevenueExpenditureNet Profit
Margin Trend
percentageOPM %NPM %
| Period | Q4 FY2026 | Q3 FY2026 | Q2 FY2026 | Q1 FY2026 | Q4 FY2025 | Q3 FY2025 | Q2 FY2025 |
|---|---|---|---|---|---|---|---|
| INCOME | |||||||
| Revenue | 0.00 | 0.00-100.0% | 65.62-78.1% | 299.91+1313.9% | 21.21+140.0% | 8.84-64.0% | 24.55 |
| Other Income | 0.00-100.0% | 1.46 | 0.00 | 0.00-100.0% | 1.91 | — | — |
| Total Income | 0.00-100.0% | 1.46-97.8% | 65.62-78.1% | 299.91+1197.1% | 23.12+161.6% | 8.84-64.0% | 24.55 |
| EXPENSES | |||||||
| Expenditure | 49.86+128408.8% | 0.04-99.9% | 54.26-79.8% | 268.78+1205.9% | 20.58+159.7% | 7.92-65.1% | 22.71 |
| Tax | 0.00-100.0% | 0.36-87.5% | 2.86-63.5% | 7.84 | 0.00-100.0% | 0.50 | — |
| PROFIT | |||||||
| PBT | -49.86-3597.8% | 1.43-87.5% | 11.36-63.5% | 31.14+1126.2% | 2.54+177.8% | 0.91-50.3% | 1.84 |
| Net Profit | -49.86-4774.4% | 1.07-87.5% | 8.50-63.5% | 23.30+817.6% | 2.54+511.9% | 0.41-77.4% | 1.84 |
| KEY METRICS | |||||||
| OPM % | — | — | 17.33%+6.95pp | 10.38%+7.38pp | 3.00% | — | — |
| NPM % | — | 72.85%+59.89pp | 12.96%+5.19pp | 7.77%-3.21pp | 10.98%+6.28pp | 4.70%-2.79pp | 7.49% |
| EPS | 0.40+207.7% | 0.13-82.9% | 0.76-63.3% | 2.07+527.3% | 0.33+725.0% | 0.04-75.0% | 0.16 |
Corporate Events
Board MeetingWELCURE
202619Jun
Board Meeting
The Board of Directors considered and accepted the resignati…
BSE Filing ↗ Board MeetingWELCURE
202629May
Board Meeting
To consider and approve the Audited financial results of the…
BSE Filing ↗ Board MeetingWELCURE
20256Dec
Board Meeting
Review of past business operations, Investment-related matte…
BSE Filing ↗ Board MeetingWELCURE
202527Sep
Board Meeting
Take on record and deliberate upon the Letter of Intent (LOI…
BSE Filing ↗ Board MeetingWELCURE
202528Aug
Board Meeting
Proposed Agro-Pharma Research Laboratory, Proposed Fund-Rais…
BSE Filing ↗ Board MeetingWELCURE
202421Oct
Board Meeting
Consider Forfeiture of Partly Paid-up Equity Shares
BSE Filing ↗ Board MeetingWELCURE
20242Sep
Board Meeting
To approve the Notice of 32" Annual General Meeting and to a…
BSE Filing ↗ Board MeetingWELCURE
202410Jun
Board Meeting
augmenting the financial resources of the company, increasin…
BSE Filing ↗ Board MeetingWELCURE
202428May
Board Meeting
Consider and approve Audited Standalone Financial Results of…
BSE Filing ↗